Chronic Migraine Headache
Neurology
1
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Vedanta BiosciencesMA - Cambridge
1 program1
liquid embolic agent SQUID 12, liquid embolic agent SQUID 18Phase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
2027
Vedanta Biosciencesliquid embolic agent SQUID 12, liquid embolic agent SQUID 18
Clinical Trials (1)
Total enrollment: 30 patients across 1 trials
Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine
Start: Oct 2024Est. completion: May 202730 patients
Phase 1Recruiting
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
11h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
11h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
11h ago
Director of Finance
CoMind
London, UK
11h ago
Electronics Engineering Manager
CoMind
London, UK
11h ago
Director of Information Technology
Zavation Medical Products
11h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 30 patients
1 companies competing in this space